These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes. Andreassen OA; McEvoy LK; Thompson WK; Wang Y; Reppe S; Schork AJ; Zuber V; Barrett-Connor E; Gautvik K; Aukrust P; Karlsen TH; Djurovic S; Desikan RS; Dale AM; Hypertension; 2014 Apr; 63(4):819-26. PubMed ID: 24396023 [TBL] [Abstract][Full Text] [Related]
3. Are minor gene effects of clinical importance? Melander O J Hypertens; 2007 Mar; 25(3):505-7. PubMed ID: 17278962 [No Abstract] [Full Text] [Related]
4. Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension Therapy. Magavern EF; Kapil V; Saxena M; Gupta A; Caulfield MJ Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):784-793. PubMed ID: 38385287 [TBL] [Abstract][Full Text] [Related]
5. Genetic mechanisms of human hypertension and their implications for blood pressure physiology. Seidel E; Scholl UI Physiol Genomics; 2017 Nov; 49(11):630-652. PubMed ID: 28887369 [TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group. Irvin MR; Sitlani CM; Floyd JS; Psaty BM; Bis JC; Wiggins KL; Whitsel EA; Sturmer T; Stewart J; Raffield L; Sun F; Liu CT; Xu H; Cupples AL; Tanner RM; Rossing P; Smith A; Zilhão NR; Launer LJ; Noordam R; Rotter JI; Yao J; Li X; Guo X; Limdi N; Sundaresan A; Lange L; Correa A; Stott DJ; Ford I; Jukema JW; Gudnason V; Mook-Kanamori DO; Trompet S; Palmas W; Warren HR; Hellwege JN; Giri A; O'donnell C; Hung AM; Edwards TL; Ahluwalia TS; Arnett DK; Avery CL Am J Hypertens; 2019 Nov; 32(12):1146-1153. PubMed ID: 31545351 [TBL] [Abstract][Full Text] [Related]
7. The future of pharmacogenetics in the treatment of hypertension. Cunningham PN; Chapman AB Pharmacogenomics; 2019 Feb; 20(3):129-132. PubMed ID: 30808251 [No Abstract] [Full Text] [Related]
8. The multifactorial nature of hypertension: the greatest challenge for its treatment? Waeber B; Brunner HR; ; J Hypertens Suppl; 2001 Sep; 19(3):S9-16. PubMed ID: 11713851 [TBL] [Abstract][Full Text] [Related]
9. Use of gene markers to guide antihypertensive therapy. Turner ST; Schwartz GL; Chapman AB; Boerwinkle E Curr Hypertens Rep; 2001 Oct; 3(5):410-5. PubMed ID: 11551376 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of antihypertensive drugs: past, present and future. Johnson JA Pharmacogenomics; 2010 Apr; 11(4):487-91. PubMed ID: 20350127 [TBL] [Abstract][Full Text] [Related]
11. Human essential hypertension: no significant association of polygenic risk scores with antihypertensive drug responses. Sánez Tähtisalo H; Ruotsalainen S; Mars N; Porthan K; Oikarinen L; Virolainen J; Fyhrquist F; Ripatti S; Kontula KK; Hiltunen TP Sci Rep; 2020 Jul; 10(1):11940. PubMed ID: 32686723 [TBL] [Abstract][Full Text] [Related]
12. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack. Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032 [TBL] [Abstract][Full Text] [Related]
13. Heritability of daytime ambulatory blood pressure in an extended twin design. Kupper N; Willemsen G; Riese H; Posthuma D; Boomsma DI; de Geus EJ Hypertension; 2005 Jan; 45(1):80-5. PubMed ID: 15557390 [TBL] [Abstract][Full Text] [Related]
14. Genetic scoring to predict antihypertensive drug response using gene variants associated with hypertension. Cerda A; Hirata RD; Hirata MH Pharmacogenomics; 2013 Nov; 14(15):1817-18. PubMed ID: 24236481 [No Abstract] [Full Text] [Related]
15. Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but do not modify responsiveness to therapy in resistant hypertension. de Faria AP; Modolo R; Sabbatini AR; Barbaro NR; Corrêa NB; Brunelli V; Tanus-Santos JE; Fontana V; Moreno H Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):65-72. PubMed ID: 25546819 [TBL] [Abstract][Full Text] [Related]
16. A Novel Mutation in the Glucocorticoid Receptor Gene Causing Resistant Hypertension: A Case Report. Lin L; Wu X; Hou Y; Zheng F; Xu R Am J Hypertens; 2019 Oct; 32(11):1126-1128. PubMed ID: 31414133 [No Abstract] [Full Text] [Related]
17. Pharmacogenomics of left ventricular hypertrophy reversal: beyond the 'one size fits all' approach to antihypertensive therapy. Schillaci G J Hypertens; 2004 Dec; 22(12):2273-5. PubMed ID: 15614020 [No Abstract] [Full Text] [Related]
18. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH; Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549 [TBL] [Abstract][Full Text] [Related]
19. Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses. Turner ST; Boerwinkle E Pharmacogenomics; 2003 Jan; 4(1):53-65. PubMed ID: 12517286 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetics and pharmacogenomics. Searching for individual antihypertensive therapy concepts]. Brand E MMW Fortschr Med; 2003 May; 145(19):43-4. PubMed ID: 12813978 [No Abstract] [Full Text] [Related] [Next] [New Search]